BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

620 related articles for article (PubMed ID: 24403312)

  • 1. hRAD9 functions as a tumor suppressor by inducing p21-dependent senescence and suppressing epithelial-mesenchymal transition through inhibition of Slug transcription.
    Wen FC; Chang TW; Tseng YL; Lee JC; Chang MC
    Carcinogenesis; 2014 Jul; 35(7):1481-90. PubMed ID: 24403312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol induced premature senescence and inhibited epithelial-mesenchymal transition of cancer cells via induction of tumor suppressor Rad9.
    Chen KY; Chen CC; Chang YC; Chang MC
    PLoS One; 2019; 14(7):e0219317. PubMed ID: 31310624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic silencing of Aristaless-like homeobox-4, a potential tumor suppressor gene associated with lung cancer.
    Liu WB; Han F; Du XH; Jiang X; Li YH; Liu Y; Chen HQ; Ao L; Cui ZH; Cao J; Liu JY
    Int J Cancer; 2014 Mar; 134(6):1311-22. PubMed ID: 24037716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significances of contactin-1 expression in human gastric cancer and knockdown of contactin-1 expression inhibits invasion and metastasis of MKN45 gastric cancer cells.
    Chen DH; Yu JW; Wu JG; Wang SL; Jiang BJ
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2109-20. PubMed ID: 25952582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
    Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
    Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ING5 inhibits cancer aggressiveness via preventing EMT and is a potential prognostic biomarker for lung cancer.
    Zhang F; Zhang X; Meng J; Zhao Y; Liu X; Liu Y; Wang Y; Li Y; Sun Y; Wang Z; Mei Q; Zhang T
    Oncotarget; 2015 Jun; 6(18):16239-52. PubMed ID: 25938545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GSK3β controls epithelial-mesenchymal transition and tumor metastasis by CHIP-mediated degradation of Slug.
    Kao SH; Wang WL; Chen CY; Chang YL; Wu YY; Wang YT; Wang SP; Nesvizhskii AI; Chen YJ; Hong TM; Yang PC
    Oncogene; 2014 Jun; 33(24):3172-82. PubMed ID: 23851495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WSTF promotes proliferation and invasion of lung cancer cells by inducing EMT via PI3K/Akt and IL-6/STAT3 signaling pathways.
    Meng J; Zhang XT; Liu XL; Fan L; Li C; Sun Y; Liang XH; Wang JB; Mei QB; Zhang F; Zhang T
    Cell Signal; 2016 Nov; 28(11):1673-82. PubMed ID: 27449264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sohlh2 inhibits ovarian cancer cell proliferation by upregulation of p21 and downregulation of cyclin D1.
    Zhang H; Zhang X; Ji S; Hao C; Mu Y; Sun J; Hao J
    Carcinogenesis; 2014 Aug; 35(8):1863-71. PubMed ID: 24858206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-181b-3p promotes epithelial-mesenchymal transition in breast cancer cells through Snail stabilization by directly targeting YWHAG.
    Yoo JO; Kwak SY; An HJ; Bae IH; Park MJ; Han YH
    Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1601-11. PubMed ID: 27102539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteopontin up-regulates critical epithelial-mesenchymal transition transcription factors to induce an aggressive breast cancer phenotype.
    Li NY; Weber CE; Mi Z; Wai PY; Cuevas BD; Kuo PC
    J Am Coll Surg; 2013 Jul; 217(1):17-26; discussion 26. PubMed ID: 23619316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MDA-9/Syntenin-Slug transcriptional complex promote epithelial-mesenchymal transition and invasion/metastasis in lung adenocarcinoma.
    Wang LK; Pan SH; Chang YL; Hung PF; Kao SH; Wang WL; Lin CW; Yang SC; Liang CH; Wu CT; Hsiao TH; Hong TM; Yang PC
    Oncotarget; 2016 Jan; 7(1):386-401. PubMed ID: 26561205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anxa2 binds to STAT3 and promotes epithelial to mesenchymal transition in breast cancer cells.
    Wang T; Yuan J; Zhang J; Tian R; Ji W; Zhou Y; Yang Y; Song W; Zhang F; Niu R
    Oncotarget; 2015 Oct; 6(31):30975-92. PubMed ID: 26307676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FOXM1 promotes the epithelial to mesenchymal transition by stimulating the transcription of Slug in human breast cancer.
    Yang C; Chen H; Tan G; Gao W; Cheng L; Jiang X; Yu L; Tan Y
    Cancer Lett; 2013 Oct; 340(1):104-12. PubMed ID: 23856032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sef Regulates Epithelial-Mesenchymal Transition in Breast Cancer Cells.
    He Q; Gong Y; Gower L; Yang X; Friesel RE
    J Cell Biochem; 2016 Oct; 117(10):2346-56. PubMed ID: 26950413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The metastasis suppressor, N-myc downstream regulated gene 1 (NDRG1), upregulates p21 via p53-independent mechanisms.
    Kovacevic Z; Sivagurunathan S; Mangs H; Chikhani S; Zhang D; Richardson DR
    Carcinogenesis; 2011 May; 32(5):732-40. PubMed ID: 21398495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ERalpha signaling through slug regulates E-cadherin and EMT.
    Ye Y; Xiao Y; Wang W; Yearsley K; Gao JX; Shetuni B; Barsky SH
    Oncogene; 2010 Mar; 29(10):1451-62. PubMed ID: 20101232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of NF-κB by SOD2 promotes the aggressiveness of lung adenocarcinoma by modulating NKX2-1-mediated IKKβ expression.
    Chen PM; Wu TC; Wang YC; Cheng YW; Sheu GT; Chen CY; Lee H
    Carcinogenesis; 2013 Nov; 34(11):2655-63. PubMed ID: 23784082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the epithelial to mesenchymal transition and metastasis by Raf kinase inhibitory protein-dependent Notch1 activity.
    Noh HS; Hah YS; Ha JH; Kang MY; Zada S; Rha SY; Kang SS; Kim HJ; Park JY; Byun JH; Hahm JR; Shin JK; Jeong SH; Lee YJ; Kim DR
    Oncotarget; 2016 Jan; 7(4):4632-46. PubMed ID: 26716415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of MCF-7 cells with aggressive metastatic potential in vitro and in vivo.
    Ziegler E; Hansen MT; Haase M; Emons G; Gründker C
    Breast Cancer Res Treat; 2014 Nov; 148(2):269-77. PubMed ID: 25292421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.